Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma
Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma have?
Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma has 1 citations in the OpenAlex counts ScholarIQ stores.
When was Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma published?
Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma has 2022 year in the ScholarIQ index.
What is the open-access status of Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma?
Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma has hybrid oa status in the ScholarIQ index.
What is the DOI of Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma?
The DOI for Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma is on the source record.
What is the PMID of Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma?
The PMID for Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma is on the source record.
What is the OpenAlex record for Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma?
The OpenAlex for Intranasal administration of nucleus-deliverable GATA3-TMD alleviates the symptoms of allergic asthma is on the source record.